Pharma and Healthcare Market Research Reports

Tuesday, 25 November 2014

BRICSS Cardiac Prosthetic Heart Valves Sector to Worth US$468 million by 2016, Find New Report

Prosthetic Heart Valves - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

The Cardiac Prosthetic Heart Valves market value is expected to reach US$468 million by 2016, primarily supported by the product types - Mechanical Heart Valves, Transluminal Heart Valves and Tissue Heart Valves. China accounts for nearly 26% of the market share and India claims more than 20% of the total share. In terms of CAGR, India is the fastest growing region while China and South Korea are just behind. Among the product types, Mechanical Heart Valves account nearly half of the market value while Tissue Heart Valves and Transluminal Heart Valves segments add up to the remaining share.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

Report Focus:

The report ‘Prosthetic Heart Valves - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments.The study reveals profitable investment strategies for market start-ups,pharmaceutical/biotechnology companies, laboratories,Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyersand many more in preferred locations.

The report primarily focuses on:

Emerging Market Trends
Advancements in the Technological Space
Market Demand of The Segments (By-Region)
Key Growth Areas and Market Size
Region-Wise Demand Factor
Key Competitors Edge
Investment Strategies

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

The analysis primarily deals with by type. Further, the subdivided categories include:

Prosthetic Heart Valves – By Type

1.Mechanical Heart Valves

a.Percutaneous Implantation

i.Stent Framed

ii.Stent Non-Framed

b.Sternotomy/Thoracotomy Implantation

i.Bi-Leaflet

ii.Tilting Disk

iii.Ball and Cage

iv.Tri-Leaflet

2.Bio-Prosthetic/Tissue Heart Valves&

a.Heterografts/Xenograft

b.Homografts/Allograft/Isograft/Autografts

3.Transluminal / Non-Invasive Heart Valves

a.Exchangeable Heart Valve (Without Stent)

b.Expandable Heart Valve

The period considered for the prosthetic heart valvesmarket analysis is 2012-2018. The region wise distribution of the market consists of BRICSS (Brazil,Russia, India, China, South Korea and South Africa).

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 106 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Know more about this report at – http://mrr.cm/ZFX

BRICSS Cardiac Monitoring and Diagnostic Devices Sector to Worth US$406 million by 2016, Find New Report

Cardiac Monitoring And Diagnostic Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

The Cardiac Monitoring and Diagnostic Devices market is expected to reach US$406 million by 2016, primarily supported by the segments: types - Telemetry Systems, ECG Devices and Holter Monitor. China accounts for nearly 25% of the global market share and India also claims 24%. In terms of CAGR, India is the fastest growing region while China and Russia are just behind. Event Monitors and ECG Devices together account for 34% of the market approximately to support the cardiovascular devices industry going forward.

Report Focus:

The report ‘Cardiac Monitoring And Diagnostic Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments.The study reveals profitable investment strategies for market start-ups,pharmaceutical/biotechnology companies, laboratories,Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyersand many more in preferred locations.

The report primarily focuses on:

Emerging Market Trends
Advancements in the Technological Space
Market Demand of The Segments (By-Region)
Key Growth Areas and Market Size
Region-Wise Demand Factor
Key Competitors Edge
Investment Strategies

The analysis primarily deals with by type &end-use. Further, the subdivided categories include:

Cardiac Monitoring and Diagnostic Devices - By Type & End-Use

- By Type

1.Cardiac Telemetry Systems or Autodetect Recorders

a.Patient Digital Transmitters

b.Electrical Leads

c.Distributed Receiving Antenna

d.Central Display/Control/Recording Station

2.Event Monitors

a.Postevent Recorders

b.Continuous Loop Recorders (CLR)

c.Implantable Loop Recorder (ILR)

3.Electrocardiogram Devices (ECG)

a.Resting ECG

b.Stress ECG or Tread Mill Test (TMT)

4.Holter Monitors (Wire and Wireless)

5.Other

a.Echocardiography (echo)

b.Heart X-Rays

c.Radionuclide Ventriculography or Multiple-Gated Acquisition Scanning (MUGA)

- By End-Use

Hospitals/Physician Clinic (Continuous Glucose Monitors)

Home/Emergency

Research and Development (Clinical Trials, Universities, CRO)

The period considered for the cardiac monitoring and diagnostic devicesmarket analysis is 2012-2018. The region wise distribution of the market consists of BRICSS (Brazil,Russia, India, China, South Korea and South Africa).

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 143 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Know more about this report at – http://mrr.cm/ZF8

Global Cardiac Defibrillators Sector to Worth US$10 billion by 2016, Find New Report

Cardiac Defibrillators - Global Trends, Estimates and Forecasts, 2012-2018

Global Cardiac Defibrillators market value is expected to reach US$10 billion by 2016. The North American segment accounts for nearly 40% (2015) of the global market share while Europe claims approximately 30% (2018). Asia-Pacific is the fastest growing region with a CAGR of 11% driving a market value of US$2.2 billion by 2016.

On a global scale, projections for Implantable Cardioverter Defibrillators (ICD) market share indicate more than half of Cardiac Defibrillators by 2015. Cardiac Defibrillators adopt monophasic technology forecasts to grow at a faster CAGR of 9.7%, in comparison with biphasic technology devices.

Report Focus:

The report ‘Cardiac Defibrillators - Global Trends, Estimates and Forecasts, 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments.The study reveals profitable investment strategies for market start-ups,pharmaceutical/biotechnology companies, laboratories,Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyersand many more in preferred locations.

The report primarily focuses on:

Emerging Market Trends
Advancements in the Technological Space
Market Demand of The Segments (By-Region)
Key Growth Areas and Market Size
Region-Wise Demand Factor
Key Competitors Edge
Investment Strategies

The analysis primarily deals with by type and technology. Further, the subdivided categories include:

Cardiac Defibrillators – By Type & Technology

- By Type

Implantable Cardioverter Defibrillators (ICD)
Automated External Defibrillators (AED)

- By Technology

Biphasic
Monophasic

The period considered for the cardiac defibrillatorsmarket analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific)), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World).The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 169 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Know more about this report at – http://mrr.cm/ZF7

Global Cardiac Pacemaker Devices Market Value to Worth US$5.7 billion by 2016, Find New Report

Cardiac Pacemakers - Global Trends, Estimates and Forecasts, 2012-2018

Global Cardiac Pacemaker sector is projected to reach US$5.7 billion by 2016. The North American segment accounts for nearly 40% (2015) of the global market share while Europe claims approximately 30% (2018). Asia-Pacific is the fastest growing region with a CAGR of 11.4% driving a market value of US$728 million by 2015. On a global scale, projections for Implantable Pacemakers market share indicates more than 50% by 2015 leaving the rest of the market to the External Pacemakers.

Report Focus:

The report ‘Cardiac Pacemakers - Global Trends, Estimates and Forecasts, 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments.The study reveals profitable investment strategies for market start-ups,pharmaceutical/biotechnology companies, laboratories,Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyersand many more in preferred locations.

The report primarily focuses on:

Emerging Market Trends
Advancements in the Technological Space
Market Demand of The Segments (By-Region)
Key Growth Areas and Market Size
Region-Wise Demand Factor
Key Competitors Edge
Investment Strategies

The analysis primarily deals with by type. Further, the subdivided categories include:

Cardiac Pacemakers– By Type

a.Implantable Pacemakers

i.Single-Chamber Pacemakers

ii.Dual-Chamber Pacemakers

iii.Biventricular Pacemakers

b.External Pacemakers

The period considered for the cardiac pacemakers devicesmarket analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific)), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World).The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 133 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Know more about this report at – http://mrr.cm/ZFh

Global Cardiac Resynchronization Therapy (CRT) Market Value to Worth US$3.1 billion by 2016, Find New Report

Cardiac Resynchronization Therapy (CRT) Devices - Global Trends, Estimates and Forecasts, 2012-2018

Global Cardiac Resynchronization Therapy (CRT) sector is projected to reach US$3.1 billion by 2016. The North America accounts for nearly 39% (2015) of the global value while Europe claims approximately 32% (2018). Asia-Pacific is the fastest growing region with a CAGR of 12.8% driving a market value of US$590 million by 2016. On a global scale, projections for Cardiac Resynchronization Therapy Defibrillator (CRT-D) market value indicate US$1.6 billion by 2016 leaving the rest of the market to the Cardiac Resynchronization Pacemakers (CRT-P).

Report Focus:

The report ‘Cardiac Resynchronization Therapy (CRT) Devices - Global Trends, Estimates and Forecasts, 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments.The study reveals profitable investment strategies for market start-ups,pharmaceutical/biotechnology companies, laboratories,Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyersand many more in preferred locations.

The report primarily focuses on:

Emerging Market Trends
Advancements in the Technological Space
Market Demand of The Segments (By-Region)
Key Growth Areas and Market Size
Region-Wise Demand Factor
Key Competitors Edge
Investment Strategies

The analysis primarily deals with by type. Further, the subdivided categories include:

Cardiac Resynchronization Therapy (CRT) Devices – By Type

Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Cardiac Resynchronization Pacemakers (CRT-P)

The period considered for the cardiac resynchronization therapy (CRT) devices market analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific)), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World).The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 130 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Know more about this report at – http://mrr.cm/ZFn

Global Cardiac Catheters Sector Market Value to Worth US$8.3 billion by 2016, Find New Report

Cardiac Catheters - Global Trends, Estimates and Forecasts, 2012-2018

Global Cardiac Catheters sector is projected to reach US$8.3 billion market value by 2016. The North America accounts for nearly 29% (2015) of the global value while Europe claims approximately 28% (2018). Asia-Pacific is the fastest growing region with a CAGR of 13.4% driving a market value of US$2.3 billion by 2015. On a global scale, projections for Electrophysiology (EP) Catheters indicates more than 45% market share by 2015 leaving the rest of the market to the PTCA and PTA Balloons, Angiography Catheters, Intravascular Ultrasound (IVUS) and other devices. PTCA Guidewires in terms of volume is expected to reach 689.9 thousand units by end of 2018.

Report Focus:

The report ‘Cardiac Catheters - Global Trends, Estimates and Forecasts, 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments.The study reveals profitable investment strategies for market start-ups,pharmaceutical/biotechnology companies, laboratories,Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyersand many more in preferred locations.

The report primarily focuses on:

Emerging Market Trends
Advancements in the Technological Space
Market Demand of The Segments (By-Region)
Key Growth Areas and Market Size
Region-Wise Demand Factor
Key Competitors Edge
Investment Strategies

The analysis primarily deals with by type. Further, the subdivided categories include:

Cardiac Catheters – By Type

a.Electrophysiology (EP) Catheters

i.Diagnostic Electrophysiology Catheters

ii.EP Ablation Catheters

b.PTCA (Percutaneous Transluminal Coronary Angioplasty) Balloons Catheters

c.Intravascular Ultrasound (IVUS)

d.PTA (Percutaneous Transluminal Angioplasty) Balloon Catheters

i.FW Balloons

ii.Cable Wire Balloons

iii.Rx Balloons

e.Guiding Catheters

f.Angiography Catheters

g.Pulmonary Artery Catheters (PAC)

h.Inflation Devices & Accessories

The period considered for the cardiac cathetersmarket analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific)), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World).The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 197 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Know more about this report at – http://mrr.cm/ZFe

Global Electrocardiogram Devices (ECG) Market Value to Worth US$330 million by 2016, Find New Report

Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018

Global Electrocardiogram Devices (ECG) sector is projected to reach US$330 million by 2016. The North America accounts for nearly 36% (2015) of the global market share while Europe claims approximately 27% (2018). Asia-Pacific is the fastest growing region with a CAGR of 10.4% driving a market value of US$79 million by 2015. On a global scale, projections for Stress ECG market share indicate more than 40% leaving the rest of the market to the Resting ECG and observed to be the fastest growing segment during the period.

Report Focus:

The report ‘Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments.The study reveals profitable investment strategies for market start-ups,pharmaceutical/biotechnology companies, laboratories,Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyersand many more in preferred locations.

The report primarily focuses on:

Emerging Market Trends
Advancements in the Technological Space
Market Demand of The Segments (By-Region)
Key Growth Areas and Market Size
Region-Wise Demand Factor
Key Competitors Edge
Investment Strategies

The analysis primarily deals with by type. Further, the subdivided categories include:

Electrocardiogram (ECG)Devices – By Type

The period considered for the electrocardiogram (ECG) devicesmarket analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific)), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World).The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 59 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Know more about this report at – http://mrr.cm/ZFs